BRAF and melanoma: Although some studies have found that BRAF mutations are an independent favorable prognostic factor, showing better overall survival than BRAF wild-type tumors [9,31,32], other investigators suggest either that the presence of any mutation in the BRAF gene increases the risk of death in melanoma patients [31,33] or that there is no correlation between BRAF mutation and prognosis [34,35].